Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Oxindole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1078590C reveals a catalytic hydrogenation route for 2-oxindole. Achieve cost reduction in API manufacturing with high-purity intermediates and scalable supply.
Novel Rh-catalyzed one-pot route for spiro-oxindoles. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for oncology drug development.
Patent CN111825686A reveals a novel [4+3] cycloaddition for oxazepino[3,2-b]indoles. Efficient, mild conditions enable cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102351777A details a novel organocatalytic route for chiral oxindoles. This report analyzes the cost-effective, metal-free synthesis for pharmaceutical intermediates.
Patent CN104693194B details organic base catalysis for oxindole derivatives offering cost reduction and high purity for pharmaceutical supply chains.
Patent CN113548999A details a novel Pd-catalyzed route to 3-(2,3-butadienyl)oxindoles with high enantioselectivity, offering cost-effective solutions for antiviral drug development.
Patent CN113548999B details a Pd-catalyzed route for chiral oxindoles. Offers high enantioselectivity and scalable antiviral intermediate production.
Patent CN120289344A details metal-free C3-functionalization for high purity pharmaceutical intermediates with reduced environmental impact and scalable production capabilities for global supply chains.
Novel copper-catalyzed route for 2-indolones offers high yield and simplified processing for reliable pharmaceutical intermediate supply chains.
Novel Rh-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates with AURKA inhibitory activity and scalable production capabilities.
Patent CN112194608A details a visible-light promoted synthesis method offering high yields and mild conditions for pharmaceutical intermediates.
Patent CN113666862A details a novel nickel-catalyzed asymmetric nitration for chiral 3-nitroindoles, offering superior stereoselectivity and cost efficiency for pharmaceutical intermediates.
Patent CN102659662A reveals a mild base-catalyzed route to 3-hydroxy-2-oxindoles using isatin, offering significant cost reduction and scalability for API manufacturing.
Patent CN113666862A reveals a nickel-catalyzed asymmetric nitration method for chiral 3-nitroindoles, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN102659662A details a mild base-catalyzed synthesis of 3-hydroxy-2-oxindoles from isatin, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Patent CN102659494A discloses a novel organocatalytic route for 3,3-disubstituted-2-oxindoles, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Advanced base-catalyzed synthesis of 3-hydroxy-2-oxindole intermediates. Delivers high purity, scalable production, and significant cost reduction for pharmaceutical manufacturing.
Patent CN102659494B details a novel chiral organic catalytic method for high-purity 3,3-disubstituted-2-oxindoles, offering significant cost and supply chain advantages.
Patent CN108409630B reveals a green aqueous method for 3-hydroxy-2-indolones using t-BuOOH, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel asymmetric synthesis method enables high-purity chiral spiro pyrrolidine oxindole intermediates with simplified process and enhanced supply chain reliability for pharmaceutical applications.